Your browser doesn't support javascript.
loading
Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival.
Oba, Junna; Nakahara, Takeshi; Abe, Takeru; Hagihara, Akihito; Moroi, Yoichi; Furue, Masutaka.
Afiliación
  • Oba J; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nakahara T; Division of Skin Surface Sensing, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: nakahara@dermatol.med.kyushu-u.ac.jp.
  • Abe T; Faculty of Human Sciences, Waseda University, Tokyo, Japan.
  • Hagihara A; Department of Health Services Management and Policy, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Moroi Y; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Furue M; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
J Am Acad Dermatol ; 70(5): 954-6, 2014 May.
Article en En | MEDLINE | ID: mdl-24742844

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Antígeno B7-H1 / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2014 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Antígeno B7-H1 / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2014 Tipo del documento: Article País de afiliación: Japón